On March 18, 2026, Professor Shi Wei's research group at the Beijing Institute of Brain Science and Brain-Inspired Intelligence published a research paper entitled "6-Hydroxydopamine promotes antitumor immunity through macrophage remodeling beyond sympathetic ablation" in the journal Neuron. The study found that the neurotoxin 6-hydroxydopamine (6-OHDA) has tumor immunomodulatory functions independent of sympathetic clearance. Dr. Jialin Yu and Dr. Hao Zhang are the first authors of this paper. Congratulations!